These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase. Zhang J; Walk SF; Ravichandran KS; Garrison JC J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 induction by Mycobacterium bovis BCG enhances ROS production through targeting SHIP1. Wang J; Wu M; Wen J; Yang K; Li M; Zhan X; Feng L; Li M; Huang X Mol Immunol; 2014 Nov; 62(1):29-36. PubMed ID: 24937178 [TBL] [Abstract][Full Text] [Related]
6. SHIP1 is targeted by miR-155 in acute myeloid leukemia. Xue H; Hua LM; Guo M; Luo JM Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984 [TBL] [Abstract][Full Text] [Related]
7. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1). Zhang J; Ravichandran KS; Garrison JC J Biol Chem; 2010 Nov; 285(45):34839-49. PubMed ID: 20810657 [TBL] [Abstract][Full Text] [Related]
8. Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. Pedersen IM; Otero D; Kao E; Miletic AV; Hother C; Ralfkiaer E; Rickert RC; Gronbaek K; David M EMBO Mol Med; 2009 Aug; 1(5):288-95. PubMed ID: 19890474 [TBL] [Abstract][Full Text] [Related]
10. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085 [TBL] [Abstract][Full Text] [Related]
11. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453 [TBL] [Abstract][Full Text] [Related]
12. Regulation of FcgammaR-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3 mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup. Horan KA; Watanabe K; Kong AM; Bailey CG; Rasko JE; Sasaki T; Mitchell CA Blood; 2007 Dec; 110(13):4480-91. PubMed ID: 17682126 [TBL] [Abstract][Full Text] [Related]
13. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451 [TBL] [Abstract][Full Text] [Related]
14. Role of SHIP1 in bone biology. Iyer S; Margulies BS; Kerr WG Ann N Y Acad Sci; 2013 Mar; 1280():11-4. PubMed ID: 23551095 [TBL] [Abstract][Full Text] [Related]
16. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. Tu J; Xing Y; Guo Y; Tang F; Guo L; Xi T Int Immunopharmacol; 2012 Dec; 14(4):353-61. PubMed ID: 22982040 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675 [TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies. Ehm P; Nalaskowski MM; Wundenberg T; Jücker M Nucleus; 2015; 6(2):154-64. PubMed ID: 25723258 [TBL] [Abstract][Full Text] [Related]
19. An ENU-induced mouse mutant of SHIP1 reveals a critical role of the stem cell isoform for suppression of macrophage activation. Nguyen NY; Maxwell MJ; Ooms LM; Davies EM; Hilton AA; Collinge JE; Hilton DJ; Kile BT; Mitchell CA; Hibbs ML; Jane SM; Curtis DJ Blood; 2011 May; 117(20):5362-71. PubMed ID: 21421839 [TBL] [Abstract][Full Text] [Related]
20. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. Bradshaw WJ; Kennedy EC; Moreira T; Smith LA; Chalk R; Katis VL; Benesch JLP; Brennan PE; Murphy EJ; Gileadi O Structure; 2024 Apr; 32(4):453-466.e6. PubMed ID: 38309262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]